Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 18;65(6):e02236-20.
doi: 10.1128/AAC.02236-20. Print 2021 May 18.

In Vitro Susceptibility of Kinetoplastids to Celastroloids from Maytenus chiapensis

Affiliations

In Vitro Susceptibility of Kinetoplastids to Celastroloids from Maytenus chiapensis

Marvin J Núñez et al. Antimicrob Agents Chemother. .

Abstract

Leishmaniasis and Chagas are among the most significant neglected tropical diseases. Due to several drawbacks with the current chemotherapy, developing new antikinetoplastid drugs has become an urgent issue. In the present work, a bioassay-guided investigation of the root bark of Maytenus chiapensis on Leishmania amazonensis and Trypanosoma cruzi led to the identification of two D:A-friedo-nor-oleanane triterpenoids (celastroloids), 20β-hydroxy-tingenone (celastroloid 5) and 3-O-methyl-6-oxo-tingenol (celastroloid 8), as promising antikinetoplastid leads. They displayed higher potency on L. amazonensis promastigotes (50% inhibitory concentrations [IC50s], 0.44 and 1.12 μM, respectively), intracellular amastigotes (IC50s, 0.83 and 1.91 μM, respectively), and T. cruzi epimastigote stage (IC50s, 2.61 and 3.41 μM, respectively) than reference drugs miltefosine and benznidazole. This potency was coupled with an excellent selectivity index on murine macrophages. Mechanism of action studies, including mitochondrial membrane potential (Δψm) and ATP-level analysis, revealed that celastroloids could induce apoptotic cell death in L. amazonensis triggered by the mitochondria. In addition, the structure-activity relationship is discussed. These findings strongly underline the potential of celastroloids as lead compounds to develop novel antikinetoplastid drugs.

Keywords: Chagas disease; bioactive natural products; leishmaniasis.

PubMed Disclaimer

Figures

FIG 1
FIG 1
Flowchart of antikinetoplastid-bioguided fractionation of Maytenus chiapensis root bark.
FIG 2
FIG 2
Chemical structures of celastroloids 1 to 10 isolated from M. chiapensis roots through bioguided fractionation.
FIG 3
FIG 3
(A) Changes in the mitochondrial membrane potential (ΔΨm) of Leishmania amazonensis promastigotes after 24 h of incubation with the IC90 of the celastroloids. (B) ATP levels in relative luminescence units (RLU) of promastigotes after 24 h of incubation with the IC90 of the celastroloids. Error bars represent the standard deviations (SD). C−, negative control.

Similar articles

Cited by

References

    1. Feasey N, Wansbrough-Jones M, Mabey DCW, Solomon AW. 2010. Neglected tropical diseases. Br Med Bull 93:179–200. doi:10.1093/bmb/ldp046. - DOI - PubMed
    1. Alvar J, Aparicio P, Aseffa A, Den BM, Canavate C, Dedet JP, Gradoni L, Ter HR, Lopez-Velez R, Moreno J. 2008. The relationship between leishmaniasis and AIDS: the second 10 years. Clin Microbiol Rev 21:334–359. doi:10.1128/CMR.00061-07. - DOI - PMC - PubMed
    1. Pérez-Molina JA, Molina I. 2018. Chagas disease. Lancet 391:82–94. doi:10.1016/S0140-6736(17)31612-4. - DOI - PubMed
    1. Sundar S, Chakravarty J, Meena LP. 2019. Leishmaniasis: treatment, drug resistance and emerging therapies. Expert Opin Orphan D 7:1–10. doi:10.1080/21678707.2019.1552853. - DOI
    1. Vermelho AB, Rodrigues GC, Supuran CT. 2020. Why hasn't there been more progress in new Chagas disease drug discovery? Expert Opin Drug Discov 15:145–158. doi:10.1080/17460441.2020.1681394. - DOI - PubMed

Publication types

Substances

LinkOut - more resources